Aug 13, 2026 08:30AM
Jul 8, 2026 07:02AM
Jul 8, 2026 07:00AM
May 12, 2026 07:00AM
Jun 25, 2025 08:02AM
Jun 25, 2025 08:00AM
Aug 6, 2024 04:01PM Ligand Reports Second Quarter 2024 Financial Results
Apr 8, 2022 08:00AM
Mar 15, 2022 08:00AM
Mar 4, 2022 08:00AM
Feb 8, 2022 08:03AM
Feb 8, 2022 08:00AM
Jan 3, 2022 06:40AM
Jan 3, 2022 06:30AM Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators
Nov 10, 2021 08:30AM
Jun 4, 2021 08:01AM
Jun 4, 2021 08:00AM
May 26, 2021 08:19AM
May 26, 2021 08:00AM
May 13, 2021 04:05PM
May 12, 2021 08:00AM Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
Apr 20, 2021 08:00AM
Apr 19, 2021 08:21AM
Apr 19, 2021 08:00AM
Mar 30, 2021 08:00AM
Mar 15, 2021 08:00AM
Mar 3, 2021 07:05AM
Mar 3, 2021 07:00AM Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
Dec 2, 2020 09:28AM
Aug 25, 2020 07:14AM
Aug 25, 2020 07:04AM
Aug 25, 2020 07:00AM
Aug 25, 2020 07:00AM
Aug 6, 2018 09:27AM

1,179,809 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All